Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
lower decrease » larger decrease (Expand Search), linear decrease (Expand Search), teer decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
lower decrease » larger decrease (Expand Search), linear decrease (Expand Search), teer decrease (Expand Search)
-
3221
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
3222
-
3223
-
3224
-
3225
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
3226
-
3227
-
3228
-
3229
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
3230
-
3231
-
3232
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
3233
-
3234
-
3235
-
3236
-
3237
-
3238
-
3239
-
3240